Analysts Have Conflicting Sentiments on These Financial Companies: Morgan Stanley (MS) and Metlife (MET)
Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Morgan Stanley (MS – Research Report) and Metlife (MET – Research Report).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Morgan Stanley (MS)
J.P. Morgan analyst Kian Abouhossein maintained a Hold rating on Morgan Stanley yesterday and set a price target of $162.00. The company’s shares closed last Thursday at $184.68.
According to TipRanks.com, Abouhossein is a top 100 analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Morgan Stanley with a $184.58 average price target, which is a 0.4% upside from current levels. In a report issued on January 6, Goldman Sachs also maintained a Hold rating on the stock with a $190.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Metlife (MET)
In a report released yesterday, Michael Ward CFA from UBS maintained a Buy rating on Metlife, with a price target of $94.00. The company’s shares closed last Thursday at $79.78.
According to TipRanks.com, CFA is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Metlife with a $93.67 average price target, implying a 19.5% upside from current levels. In a report issued on January 5, J.P. Morgan also maintained a Buy rating on the stock with a $93.00 price target.
